TransEnterix (OTCMKTS:TRXDW – Get Free Report) and Inspira Technologies OXY B.H.N. (NASDAQ:QTEX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.
Analyst Ratings
This is a summary of current recommendations and price targets for TransEnterix and Inspira Technologies OXY B.H.N., as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| TransEnterix | 0 | 0 | 0 | 0 | 0.00 |
| Inspira Technologies OXY B.H.N. | 1 | 0 | 0 | 0 | 1.00 |
Valuation & Earnings
This table compares TransEnterix and Inspira Technologies OXY B.H.N.”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| TransEnterix | $8.53 million | 2.51 | -$154.20 million | ($4.22) | -0.04 |
| Inspira Technologies OXY B.H.N. | $290,000.00 | 199.58 | -$13.22 million | N/A | N/A |
Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than TransEnterix.
Volatility and Risk
TransEnterix has a beta of 2.56, suggesting that its share price is 156% more volatile than the S&P 500. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 4.11, suggesting that its share price is 311% more volatile than the S&P 500.
Profitability
This table compares TransEnterix and Inspira Technologies OXY B.H.N.’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| TransEnterix | -2,149.15% | -83.74% | -64.94% |
| Inspira Technologies OXY B.H.N. | N/A | N/A | N/A |
Insider and Institutional Ownership
8.2% of TransEnterix shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 3.1% of TransEnterix shares are held by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
Inspira Technologies OXY B.H.N. beats TransEnterix on 9 of the 10 factors compared between the two stocks.
About TransEnterix
TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.
About Inspira Technologies OXY B.H.N.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra’annana, Israel.
Receive News & Ratings for TransEnterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransEnterix and related companies with MarketBeat.com's FREE daily email newsletter.
